Pass it forward to your friends

New Post Public Reply Private Reply Replies (0) Message Board
haveittodayray
918
Calculated Risk
Top of the morning everyone. I am at an age where I pass along excellent research for anyone in the stock market. You might say pay/pass it forward to your friends. This stock went up 55% yesterday folks, but I am not selling until it reaches at least the dollar to five-dollar range. Do not buy this stock unless you can afford to lose it all or for that matter any stock. The market is a risk, and a gamble, just like Vegas, you must be willing to take a calculated risk for sure. You can trade penny stocks all year long, some are losers, some are winners, no doubt about it. First, of all do your diligent research. I spend hours of research before investing. 2 months ago, I gave you CCL at $10 and it went to $21 within 2 months. Bought SNDL last week for a 48% gain and took the profits. Also watching CANN and FFNTF. Just came across another gem with a high potential to make anyone a millionaire, that has the guts to go all in. In Vegas, you roll the dice, sometimes you get that 7/11 on the first roll and other times you crap out. Average volume about 40 million per day. This penny stock is trading about 0.0287 a share. So, an investment of 10K gets you about 500,000 shares. 20K gets you approximately a million shares. Heck, a 1000 invested gets you around 100,000 shares. Ground floor opportunity comes along at different times in your life. This just might be the one. No guarantees of course, life comes without a guarantee for sure. The Company is based in Los Angeles and is in the medical/pharmaceutical product business. Just signed a contract for 6 states, plan to be in 16 states, and eventually every state. The main product is Vitastem, but they have new ones being tested as your read this. Sometimes, you just must roll the dice and think big. Dream big and take a risk. Not for the fragile and faint of heart for sure. I have had my share of winners and losers for sure along the roller coaster of life, how about you? “Shoot for the Moon, and if you miss, your fall upon the stars” Les Brown. The stock VDRM. I am rolling the dice and all in. Short term, swing trade or day trade or long term, it is your choice. At my age just want to pass along good news, never a guarantee of course. Pass this along to 10 of your friends, and those friends pay it forward to ten more and so on and so forth. You can thank me later. Did I mention it went up over 55% today? When it goes to a dollar to five-dollar range, investors will make thousands if not millions folks. Are you all in this morning? Viaderma Inc (VDRM)
0.0287 +0.0102 (+55.14%) 02/09/21 [OTC US]
POST-MARKET 0.0290 +0.0003 (+1.05%) 15:59 ET
BARCHART OPINION for Tue, Feb 9th, 2021
Tutorial
Alerts
Watch
Help
Overall Average:
100% BUY
Overall Average Signal calculated from all 13 indicators. Signal Strength is a long-term measurement of the historical strength of the Signal, while Signal Direction is a short-term (3-Day) measurement of the movement of the Signal.
1

ViaDerma, Inc. (VDRM) Stock Research Links

VDRM Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bloomberg Law Awards Series Celebrates Legal Excellence

Updated Category News Views 24

New Awards Shine Light on Corporate Legal Teams Here's one for the books: Bloomberg Law is rolling out a shiny new awards program called Inside In-House: Legal Departments of the Year. Now, this isn't some vanity affair because it's aimed at celebrating the folks in legal teams who make companies tick behind the scenes. Openings for nominations run through November 20,...

Continue Reading
New Research Awards Target Drug Resistance in Cancers

Updated Category News Views 68

Well, this is a breath of fresh air in the lung cancer scene, let's talk about some promising news for those battling RET-positive cancers. The LUNGevity Foundation and RETpositive have handed out some well-deserved awards to researchers aiming to crack the stubborn nut of drug resistance in RET-positive cancer therapies. Changing the Game for RET-positive Cancer RET gene...

Continue Reading
Personalized Senior Living Guidance Finds Home in South Jersey

Updated Category News Views 7

Shaunique Adams and Her Mission in South Jersey In a world where compassion sometimes feels like it's on short supply, Shaunique Adams is making sure it's at the forefront of her mission. Having experienced the emotional whirlwind of caregiving firsthand, Adams has transformed her personal journey into a mission to serve families navigating similar paths. Through Trua...

Continue Reading
Firmable Climbs G2 Ranks in Sales Intelligence

Updated Category News Views 72

Success stories aren't written overnight, and Firmable's recent leap in G2's rankings proves that point. This AI-native B2B sales powerhouse has muscled its way from #8 to #4 on the global Momentum Grid for Sales Intelligence, marking a dramatic rise that's hard to ignore. Being recognized at this level shows the company's on a solid path, but let's see what makes this...

Continue Reading
Danobatgroup's New HQ in Shanghai Marks Strategic Shift

Updated Category News Views 67

Shanghai Beckons: A Game Changer for Danobatgroup One crisp morning in Shanghai marks a turning point for Danobatgroup. The Spanish heavy-hitter in machine tools has pinpointed the Shanghai Xinzhuang Industry Park in Minhang District for its Asia-Pacific headquarters. It ain't just another blip on the radar—this one's a calculated leap. Location, Location, Location...

Continue Reading
San Diego's Iconic Nightlife Venue Revives as The Quin

Updated Category News Views 140

The ghosts of PLUXX's past are getting a new home at The Quin in San Diego. It's happening in the Gaslamp Quarter, where the familiar pulse of a party will hit the scene once again. Instead of peeling walls and the typical downtown club smell, we've got internationally acclaimed DJ Sam Feldt headlining the Halloween bash—Heaven & Hell. The Quin's Next Chapter Begins on...

Continue Reading
Grupo Elektra's Earnings: Revenue Down, EBITDA Up

Updated Category News Views 49

Grupo Elektra's Third Quarter Snapshot Ever look at a company's quarterly earnings and feel like you're in a game of numbers bingo? Here's Grupo Elektra's latest—revenue down but EBITDA up. That's the headline from Latin America's retail and financial services giant, announcing a healthy Ps.53,297 million in revenue for Q3 2026, slightly dipping compared to last year's...

Continue Reading
Storyteq's AI Edge Earns Gartner Leader Status Again

Updated Category News Views 69

Pioneering AI in Digital Asset Management Alright, folks, this ain't just another tech release to gloss over with your morning coffee—ITG's Storyteq has snagged the 'Leader' title in Gartner's Magic Quadrant for Digital Asset Management. It's no small feat to earn such recognition three years running, and the secret sauce is their advanced AI capabilities. A Unified AI...

Continue Reading
Ascletis' ASC30 Achieves Significant HbA1c Reductions

Updated Category News Views 0

When you dive into the world of biopharma, you never quite know what's going to grab your attention next. Today, it's Ascletis Pharma's (HKEX: 1672) GLP-1 receptor agonist, ASC30, that's piqued my interest. It just wrapped up a U.S. Phase II study with a bang, showing off with some impressive results for type 2 diabetes treatment. This ain't no half-hearted...

Continue Reading
Markel Stays the Course: Solid Q3 Results in 2026

Updated Category News Views 70

Markel Group's Steady Climb Doesn't Falter Diving right into it, Markel Group's latest figures prove they're not just treading water. The insurance giant, trading under NYSE:MKL, reported solid third quarter results for 2026. And while some numbers might not be breaking records, they sure paint a picture of a company that's weathering the market with some grit. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Corcept Therapeutics Faces Class Action Amidst FDA Warnings

Updated Category News Views 161

Corcept's Legal Woes: A Major Shareholder Sucker Punch Alright, folks, let’s break down the hot mess that is Corcept Therapeutics. This situation rings eerily familiar—reminds me of those chaotic days during the dot-com bust. Their stock (NASDAQ:CORT), which once basked in the limelight, just took a nosedive—plummeting by 50% after news broke about some serious...

Continue Reading
ZTE and MTN Launch the World's First 5-Band Remote Radio Unit

Updated Category News Views 227

Introduction to Groundbreaking Technology ZTE Corporation, a pioneering provider in integrated technology solutions, has recently partnered with MTN, a key telecommunications operator in Africa, to unveil a significant advancement in mobile network technology. This revolutionary endeavor brings forth the world's first commercial deployment of a 5-band Remote Radio Unit...

Continue Reading
Imperial Brands Sees Share Price Surge After Positive Update

Updated Category News Views 113

Imperial Brands Shares Experience Notable Growth Shares of Imperial Brands (LON: IMB) saw an impressive increase following the company's recent trading update, indicating a strong outlook for the fiscal year. Investors reacted positively, as the tobacco giant confirmed that it is on track to meet its full-year guidance while also revealing plans to boost capital returns...

Continue Reading
Understanding the Disclosures of Warpaint London Plc In Detail

Updated Category News Views 320

Introduction to Warpaint London Plc Public Disclosures When examining the intricacies of financial markets, disclosures play a pivotal role in ensuring transparency and compliance. This article sheds light on the essential public opening position disclosures related to Warpaint London Plc, particularly focusing on key aspects and significant figures that matter. Key...

Continue Reading
Anticipating Dragonfly Energy Holdings' Earnings Release

Updated Category News Views 167

Anticipating Dragonfly Energy Holdings' Earnings Release Dragonfly Energy Hldgs (NASDAQ: DFLI) is gearing up to release its quarterly earnings report soon, with analysts closely monitoring the financial outcomes. Investors have high hopes for this earnings season, eagerly anticipating news that could exceed expectations and provide positive projections for the next...

Continue Reading